{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:24:23Z","timestamp":1787646263313,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["IMPACT ERC-PoC- 101188898"],"award-info":[{"award-number":["IMPACT ERC-PoC- 101188898"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["CoBABATI ERC-StG-678905"],"award-info":[{"award-number":["CoBABATI ERC-StG-678905"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbc.2026.111485","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:55:31Z","timestamp":1776873331000},"page":"111485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of heme on the therapeutic efficacy of anti-CD20 antibodies"],"prefix":"10.1016","volume":"302","author":[{"given":"Annaelle","family":"Marey-Jarossay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin V.","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Lecerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Cruz-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Hinan","family":"Lassouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9212-0859","authenticated-orcid":false,"given":"Laurent","family":"Gilardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tareste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas V.","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Siberil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Teillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8536-8995","authenticated-orcid":false,"given":"Jordan D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111485_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2004.02.004","article-title":"Polyreactivity of antibody molecules","volume":"25","author":"Notkins","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2007.07.015","article-title":"Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells","volume":"29","author":"Zhou","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jbc.2026.111485_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BCJ20180670","article-title":"Antibody specificity and promiscuity","volume":"476","author":"Jain","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111485_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2026.111485_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan6619","article-title":"Natural polyreactive IgA antibodies coat the intestinal microbiota","volume":"358","author":"Bunker","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111485_bib6","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.celrep.2019.08.056","article-title":"Affinity maturation enhances antibody specificity but compromises conformational stability","volume":"28","author":"Shehata","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111485_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chom.2007.01.002","article-title":"The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies","volume":"1","author":"Zhou","year":"2007","journal-title":"Cell Host Microb."},{"key":"10.1016\/j.jbc.2026.111485_bib8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111485_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1999195","article-title":"Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns","volume":"13","author":"Cunningham","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2026.111485_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41570-022-00438-x","article-title":"Non-specificity as the sticky problem in therapeutic antibody development","volume":"6","author":"Ausserwoger","year":"2022","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01541346","article-title":"Half-life of polyreactive antibodies","volume":"14","author":"Sigounas","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib12","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.1408766112","article-title":"Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics","volume":"112","author":"Schoch","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111485_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2223350","article-title":"Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain","volume":"15","author":"Kwon","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2026.111485_bib14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111485_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/19420862.2017.1356529","article-title":"Chaperone proteins as single component reagents to assess antibody nonspecificity","volume":"9","author":"Kelly","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2026.111485_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jmb.2017.11.008","article-title":"Reduction of nonspecificity motifs in synthetic antibody libraries","volume":"430","author":"Kelly","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.111485_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/protein\/gzz002","article-title":"Net charge of antibody complementarity-determining regions is a key predictor of specificity","volume":"31","author":"Rabia","year":"2019","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jbc.2026.111485_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.molimm.2019.06.012","article-title":"Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies","volume":"112","author":"Lecerf","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib19","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111485_bib20","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41467-022-31457-3","article-title":"Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space","volume":"13","author":"Makowski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111485_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2200540","article-title":"Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches","volume":"15","author":"Jain","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2026.111485_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114801","article-title":"Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111485_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41551-023-01074-6","article-title":"Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning","volume":"8","author":"Makowski","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jbc.2026.111485_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jaut.2000.0472","article-title":"Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents","volume":"16","author":"Bouvet","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jbc.2026.111485_bib25","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1742-4658.2010.07714.x","article-title":"Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis","volume":"277","author":"Djoumerska-Alexieva","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2026.111485_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaut.2005.03.005","article-title":"Autoantibodies unmasked by redox reactions","volume":"24","author":"McIntyre","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jbc.2026.111485_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2005.07.009","article-title":"Redox-reactive autoantibodies: detection and physiological relevance","volume":"5","author":"McIntyre","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jbc.2026.111485_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1074\/jbc.M509190200","article-title":"Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G","volume":"281","author":"Dimitrov","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib29","doi-asserted-by":"crossref","first-page":"26696","DOI":"10.1074\/jbc.M702751200","article-title":"Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions","volume":"282","author":"Dimitrov","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2008.04.005","article-title":"Autoimmune and proinflammatory activity of oxidized immunoglobulins","volume":"7","author":"Omersel","year":"2008","journal-title":"Autoimm Rev."},{"key":"10.1016\/j.jbc.2026.111485_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s42003-021-01931-7","article-title":"Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities","volume":"4","author":"Lecerf","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2026.111485_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/antib11010011","article-title":"Functional changes of therapeutic antibodies upon exposure to pro-oxidative agents","volume":"11","author":"Lecerf","year":"2022","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jbc.2026.111485_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.25038","article-title":"Autoantibody potential of cancer therapeutic monoclonal antibodies","volume":"127","author":"McIntyre","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111485_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.toxlet.2005.03.004","article-title":"Free heme toxicity and its detoxification systems in human","volume":"157","author":"Kumar","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jbc.2026.111485_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2015.11.006","article-title":"Red alert: Labile heme is an alarmin","volume":"38","author":"Soares","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molmed.2016.01.004","article-title":"Heme: modulator of plasma systems in hemolytic","volume":"22","author":"Roumenina","year":"2016","journal-title":"Dis. Trends Mol Med."},{"key":"10.1016\/j.jbc.2026.111485_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fonc.2018.00163","article-title":"Past, present, and future of rituximab-the world's first oncology monoclonal antibody therapy","volume":"8","author":"Pierpont","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2026.111485_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A review of the current use of rituximab in autoimmune diseases","volume":"9","author":"Gurcan","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jbc.2026.111485_bib39","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jbc.2026.111485_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jbc.2026.111485_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.autrev.2014.11.014","article-title":"Efficacy and safety of rituximab in auto-immune hemolytic anemia: a meta-analysis of 21 studies","volume":"14","author":"Reynaud","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jbc.2026.111485_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/vox.12217","article-title":"The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease","volume":"108","author":"Noizat-Pirenne","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.jbc.2026.111485_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajh.20738","article-title":"Methemoglobin--it's not just blue: a concise review","volume":"82","author":"Umbreit","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jbc.2026.111485_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jbc.2026.111485_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.171.3.1581","article-title":"Complement activation determines the therapeutic activity of rituximab in vivo","volume":"171","author":"Di Gaetano","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib46","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2009-10-248609","article-title":"Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response","volume":"116","author":"Abes","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111485_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/leu.2014.275","article-title":"Anti-CD20 therapy induces a memory Th1 response through the IFN-gamma\/IL-12 axis and prevents protumor regulatory T-cell expansion in mice","volume":"29","author":"Deligne","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.111485_bib48","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111485_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.thromres.2004.08.008","article-title":"The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation--reduction reactions","volume":"114","author":"McIntyre","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jbc.2026.111485_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12016-008-8093-y","article-title":"Redox-reactive autoantibodies: biochemistry, characterization, and specificities","volume":"37","author":"McIntyre","year":"2009","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib51","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1074\/jbc.M114.618124","article-title":"Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity","volume":"290","author":"Lecerf","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-019-0126-7","article-title":"Breaking the law: unconventional strategies for antibody diversification","volume":"19","author":"Kanyavuz","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib53","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1515\/hsz-2022-0226","article-title":"Assessment of the breadth of binding promiscuity of heme towards human proteins","volume":"403","author":"Roumenina","year":"2022","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib54","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1021\/jacs.2c06104","article-title":"A chemical proteomic map of heme-protein interactions","volume":"144","author":"Homan","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111485_bib55","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1074\/jbc.M701654200","article-title":"Structural basis for recognition of CD20 by therapeutic antibody rituximab","volume":"282","author":"Du","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111485_bib56","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jimmun\/vkaf015","article-title":"HIV-1 broadly neutralizing antibodies demonstrate a high propensity for binding to heme","volume":"214","author":"Lacombe","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111485_bib58","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.2022015596","article-title":"Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics","volume":"140","author":"Vallelian","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.111485_bib59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(25)12446-2","article-title":"The mechanism of oxidative hemolysis produced by phenylhydrazine","volume":"13","author":"Goldberg","year":"1977","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111485_bib60","first-page":"5381","article-title":"Significance of blood vessel leakiness in cancer","volume":"62","author":"McDonald","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.111485_bib61","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know?","volume":"100","author":"Nagy","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111485_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.00199914","article-title":"A bleeding problem in lung cancer patients","volume":"45","author":"Depuydt","year":"2015","journal-title":"Eur. Resp J."},{"key":"10.1016\/j.jbc.2026.111485_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108181","article-title":"Scavenging of labile heme by hemopexin is a key checkpoint in cancer growth and metastases","volume":"32","author":"Canesin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.111485_bib64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41590-021-00921-5","article-title":"Heme catabolism by tumor-associated macrophages controls metastasis formation","volume":"22","author":"Consonni","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2026.111485_bib65","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174528","article-title":"Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance","volume":"134","author":"Schaer","year":"2023","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jbc.2026.111485_bib66","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826003571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826003571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:40:10Z","timestamp":1787643610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826003571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0021925826003571"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111485","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of heme on the therapeutic efficacy of anti-CD20 antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111485"}}